Last reviewed · How we verify
DVD-R
At a glance
| Generic name | DVD-R |
|---|---|
| Also known as | Decadron, Velcade, Doxil, Revlimid |
| Sponsor | Oncotherapeutics |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma (PHASE2)
- Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery (NA)
- Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DVD-R CI brief — competitive landscape report
- DVD-R updates RSS · CI watch RSS
- Oncotherapeutics portfolio CI